Research programme: pain therapeutics - Dompe

Drug Profile

Research programme: pain therapeutics - Dompe

Alternative Names: BKB1r antagonists - Dompe; c5ar antagonists - Dompe

Latest Information Update: 19 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dompe Farmaceutici
  • Class Analgesics
  • Mechanism of Action Bradykinin B1 receptor antagonists; Complement C5a receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Neuropathic pain; Pain

Most Recent Events

  • 19 Jul 2016 Early research is ongoing in Italy
  • 31 Mar 2011 Early research in Neuropathic pain in Italy (unspecified route)
  • 31 Mar 2011 Early research in Pain in Italy (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top